These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 21552268)

  • 1. Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors.
    Delahaye NF; Rusakiewicz S; Martins I; Ménard C; Roux S; Lyonnet L; Paul P; Sarabi M; Chaput N; Semeraro M; Minard-Colin V; Poirier-Colame V; Chaba K; Flament C; Baud V; Authier H; Kerdine-Römer S; Pallardy M; Cremer I; Peaudecerf L; Rocha B; Valteau-Couanet D; Gutierrez JC; Nunès JA; Commo F; Bonvalot S; Ibrahim N; Terrier P; Opolon P; Bottino C; Moretta A; Tavernier J; Rihet P; Coindre JM; Blay JY; Isambert N; Emile JF; Vivier E; Lecesne A; Kroemer G; Zitvogel L
    Nat Med; 2011 Jun; 17(6):700-7. PubMed ID: 21552268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-fitness status of peripheral NK cells defined by decreased NKp30 and perforin, and increased soluble B7H6, in cervical cancer patients.
    Gutierrez-Silerio GY; Bueno-Topete MR; Vega-Magaña AN; Bastidas-Ramirez BE; Gutierrez-Franco J; Escarra-Senmarti M; Pedraza-Brindis EJ; Peña-Rodriguez M; Ramos-Marquez ME; Delgado-Rizo V; Banu N; Alejandre-Gonzalez AG; Fafutis-Morris M; Haramati J; Del Toro-Arreola S
    Immunology; 2023 Mar; 168(3):538-553. PubMed ID: 36271832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.
    Rusakiewicz S; Perier A; Semeraro M; Pitt JM; Pogge von Strandmann E; Reiners KS; Aspeslagh S; Pipéroglou C; Vély F; Ivagnes A; Jegou S; Halama N; Chaigneau L; Validire P; Christidis C; Perniceni T; Landi B; Berger A; Isambert N; Domont J; Bonvalot S; Terrier P; Adam J; Coindre JM; Emile JF; Poirier-Colame V; Chaba K; Rocha B; Caignard A; Toubert A; Enot D; Koch J; Marabelle A; Lambert M; Caillat-Zucman S; Leyvraz S; Auclair C; Vivier E; Eggermont A; Borg C; Blay JY; Le Cesne A; Mir O; Zitvogel L
    Oncoimmunology; 2017; 6(1):e1137418. PubMed ID: 28197361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered NCR3 Splice Variants May Result in Deficient NK Cell Function in Renal Cell Carcinoma Patients.
    Wang X; Huang L; Wen X; Li D; Yang G; Zheng J
    In Vivo; 2024; 38(1):174-183. PubMed ID: 38148073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients.
    Ménard C; Blay JY; Borg C; Michiels S; Ghiringhelli F; Robert C; Nonn C; Chaput N; Taïeb J; Delahaye NF; Flament C; Emile JF; Le Cesne A; Zitvogel L
    Cancer Res; 2009 Apr; 69(8):3563-9. PubMed ID: 19351841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7H6-derived peptides trigger TNF-α-dependent immunostimulatory activity of lymphocytic NK92-MI cells.
    Phillips M; Romeo F; Bitsaktsis C; Sabatino D
    Biopolymers; 2016 Sep; 106(5):658-72. PubMed ID: 27216712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor.
    Vitale M; Della Chiesa M; Carlomagno S; Pende D; Aricò M; Moretta L; Moretta A
    Blood; 2005 Jul; 106(2):566-71. PubMed ID: 15784725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKp30 isoforms in patients with chronic hepatitis C virus infection.
    Mantovani S; Mele D; Oliviero B; Barbarini G; Varchetta S; Mondelli MU
    Immunology; 2015 Oct; 146(2):234-42. PubMed ID: 26094914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint.
    Shemesh A; Kugel A; Steiner N; Yezersky M; Tirosh D; Edri A; Teltsh O; Rosental B; Sheiner E; Rubin E; Campbell KS; Porgador A
    Oncotarget; 2016 Oct; 7(43):70912-70923. PubMed ID: 27765926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.
    Golden-Mason L; Cox AL; Randall JA; Cheng L; Rosen HR
    Hepatology; 2010 Nov; 52(5):1581-9. PubMed ID: 20812318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma.
    Mantovani S; Oliviero B; Lombardi A; Varchetta S; Mele D; Sangiovanni A; Rossi G; Donadon M; Torzilli G; Soldani C; Porta C; Pedrazzoli P; Chiellino S; Santambrogio R; Opocher E; Maestri M; Bernuzzi S; Rossello A; Clément S; De Vito C; Rubbia-Brandt L; Negro F; Mondelli MU
    Hepatology; 2019 Mar; 69(3):1165-1179. PubMed ID: 30153337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
    Queiroz GAN; Mascarenhas REM; Vieillard V; Andrade RL; Galvão-Castro B; Grassi MFR
    BMC Infect Dis; 2019 May; 19(1):433. PubMed ID: 31101076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles for the NK cell-activating receptors in mediating interactions with dendritic cells and tumor cells.
    Wai LE; Garcia JA; Martinez OM; Krams SM
    J Immunol; 2011 Jan; 186(1):222-9. PubMed ID: 21106845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome.
    Hervier B; Perez M; Allenbach Y; Devilliers H; Cohen F; Uzunhan Y; Ouakrim H; Dorgham K; Méritet JF; Longchampt E; Stenzel W; Cremer I; Benveniste O; Vieillard V
    J Immunol; 2016 Sep; 197(5):1621-30. PubMed ID: 27511738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution.
    Messaoudene M; Fregni G; Enot D; Jacquelot N; Neves E; Germaud N; Garchon HJ; Boukouaci W; Tamouza R; Chanal J; Avril MF; Toubert A; Zitvogel L; Rusakiewicz S; Caignard A
    Oncoimmunology; 2016; 5(12):e1154251. PubMed ID: 28123867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.
    Pogge von Strandmann E; Simhadri VR; von Tresckow B; Sasse S; Reiners KS; Hansen HP; Rothe A; Böll B; Simhadri VL; Borchmann P; McKinnon PJ; Hallek M; Engert A
    Immunity; 2007 Dec; 27(6):965-74. PubMed ID: 18055229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles.
    Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30.
    Balsamo M; Zambello R; Teramo A; Pedrazzi M; Sparatore B; Scordamaglia F; Pende D; Mingari MC; Moretta L; Moretta A; Semenzato G; Vitale M
    Exp Hematol; 2009 Oct; 37(10):1167-75. PubMed ID: 19580844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel single nucleotide substitutions in the NKp30 gene expressed in human natural killer cells.
    Sato M; Ohashi J; Tsuchiya N; Tadokoro K; Juji T; Hanaoka K; Tokunaga K; Yabe T
    Tissue Antigens; 2001 Oct; 58(4):255-8. PubMed ID: 11782277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.
    Xu X; Li Y; Gauthier L; Chen Q; Vivier E; Mariuzza RA
    Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):697-701. PubMed ID: 26057798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.